Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0896
+0.0080 (9.80%)
Aug 17, 2026, 4:49 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 109.99 million as of August 17, 2026. Its market cap has decreased by -35.07% in one year.
Market Cap
109.99M
Enterprise Value
117.54M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 109.99M, a decrease of -85.66%. That is a compound annual growth rate of -43.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 109.99M | -4.07% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Coloplast | 96.44B |
| Demant | 62.72B |
| Gubra | 6.07B |
| BioPorto | 591.66M |
| ViroGates | 101.17M |
| Scandinavian Medical Solutions | 83.14M |